Clinical trial
Effectiveness of Text Messaging on Risk Factors Control and Medication Adherence Among Coronary Heart Disease Patients Without Diabetes in Cardiovascular Health and Texting Messaging (CHAT) Study
NCT02888769 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Text Messaging on Risk Factors Control and Medication Adherence Among Coronary Heart Disease Patients Without Diabetes in Cardiovascular Health and Texting Messaging (CHAT) Study
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- November 30, 2017
- Enrollment
- 822 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.